HT
IRWD icon

HAP Trading’s Ironwood Pharmaceuticals IRWD Stock Holding History

HAP Trading’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-133,000
Closed -$16.6K – 755
2024
Q1 		$16.6K Buy
+133,000
New +$1.61M ﹤0.01% 546
2015
Q4 		– Sell
-26,268
Closed -$57K – 1030
2015
Q3 		$57K Hold
26,268
– – ﹤0.01% 684
2015
Q2 		$47K Buy
+26,268
New +$305K ﹤0.01% 672

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

HAP Trading's IRWD Position: Q4 2021 in Review

HAP Trading sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2021, closing a stake of 21,611 shares — an estimated $282K sold.

HAP Trading first reported a position in IRWD in Q4 2018 and held it in 3 quarters. The position peaked at $282K in Q3 2021. 212 funds tracked by Wall St. Rank hold IRWD as of Q4 2021.

  • HAP Trading reported no remaining Ironwood Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 21,611 Ironwood Pharmaceuticals shares in Q4 2021, an estimated $282K.
  • HAP Trading first reported a position in Ironwood Pharmaceuticals in Q4 2018 and held it in 3 quarters.
  • HAP Trading's Ironwood Pharmaceuticals position peaked at $282K in Q3 2021.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.